Acasti Pharma Inc. Stock Toronto S.E.
Equities
ACST
CA00430K8730
Pharmaceuticals
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 37.15M 27.1M |
---|---|---|---|---|---|
Net income 2024 * | -18M -13.13M | Net income 2025 * | -23M -16.78M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.06
x | P/E ratio 2025 * |
-2.64
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.98% |
Latest transcript on Acasti Pharma Inc.
Managers | Title | Age | Since |
---|---|---|---|
Prashant Kohli
CEO | Chief Executive Officer | 52 | 21-07-31 |
Director of Finance/CFO | 52 | Jan. 04 | |
Carrie D'Andrea
CTO | Chief Tech/Sci/R&D Officer | 52 | 23-05-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
A. Davis
BRD | Director/Board Member | 57 | 23-10-09 |
Director/Board Member | - | 23-10-09 | |
Santosh Kottayil
BRD | Director/Board Member | - | 23-10-09 |
1st Jan change | Capi. | |
---|---|---|
+25.61% | 672B | |
+25.87% | 570B | |
-5.24% | 360B | |
+16.49% | 321B | |
+8.28% | 300B | |
+7.09% | 217B | |
-9.12% | 204B | |
+5.01% | 199B | |
-8.75% | 149B |